基因编辑新疗法可修复人体皮肤

Core Insights - A new gene-editing therapy using CRISPR technology combined with lipid nanoparticles has been developed to repair human skin, targeting various genetic skin diseases, including rare conditions and common ailments like eczema [1][2] - The therapy specifically addresses autosomal recessive congenital ichthyosis (ARCI), a rare genetic skin disorder with an incidence of approximately 1 in 100,000, characterized by extremely dry, scaly skin and chronic inflammation [1] - The new method has shown the ability to repair the most common genetic defects causing ARCI in human skin models, restoring up to 30% of normal skin function, which is significant enough for clinical improvement [1] - The CRISPR technology offers new hope for previously untreatable diseases, although applying it to skin has been challenging due to the skin's natural barrier properties [1] Technology and Methodology - The research team innovatively used lipid nanoparticles as "vehicles" to deliver gene-editing tools into cells, creating painless micro-holes in the skin using clinically approved lasers to facilitate the penetration of nanoparticles [2] - Once the nanoparticles reach the deep skin stem cells, the gene editor precisely corrects the faulty DNA, activating the skin's self-repair capabilities [2] Broader Implications - The platform technology developed by the team has broad applicability and can be quickly adapted for other genetic skin diseases [3]